Injective (INJ) is currently trading at $2.93, reflecting a slight increase of 0.79% over the past 24 hours. The daily range has been tight, with a high of $3.02 and a low of $2.90, indicating low volatility in the short term.

The trading volume stands at approximately 52.22 million, contributing to a volume-to-market cap ratio of 17.84%, which is relatively healthy. However, the hourly moving averages show a bearish sentiment, with the 8, 13, and 21 SMAs all reflecting declines, while only the 55 SMA shows a slight positive shift.

On the RSI front, the 1-hour RSI is at 43, suggesting that INJ is approaching oversold territory, but not yet in it. The 7-day RSI at 46 indicates weak momentum, and the price changes over the last week, 14 days, and 30 days have all been negative, reflecting a consistent downtrend.

Despite the recent price action, the cryptocurrency is significantly below its all-time high of $52.62, which was reached on March 14, 2024. This substantial distance from the ATH indicates potential for future growth, but current technical indicators do not suggest an immediate upward trend.

Given the weak momentum reflected in both the RSI metrics and moving averages, along with the negative price changes over multiple time frames, a cautious approach is warranted. The current market conditions suggest that INJ is not primed for a strong rally in the near term.

Rating: Hold. The lack of bullish indicators and the overall downtrend in price suggest that investors should maintain their current positions while monitoring for signs of recovery.